|
Synonyms: monoclonal antibody BEC2
Compound class:
Antibody
Comment: Mitumomab (BEC2) is an anti-idiotypic monoclonal antibody that mimics GD3 ganglioside and is being tested as a vaccination therapy in oncology.
|
Classification  |
|
| Compound class | Antibody |
| International Nonproprietary Names |
|
| INN number | INN |
| 7934 | mitumomab |
| Synonyms |
| monoclonal antibody BEC2 |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 130 |
| Other databases | |
| GtoPdb PubChem SID | 249565663 |
| Search PubMed clinical trials | mitumomab |
| Search PubMed titles | mitumomab |
| Search PubMed titles/abstracts | mitumomab |
| Wikipedia | Mitumomab |
